What is CureApp?
CureApp is at the forefront of revolutionizing healthcare treatment through innovative software solutions. The company develops evidence-based medical device programs and therapeutic applications designed to address conditions that are inadequately managed by traditional pharmaceuticals and hardware. By leveraging evolving technology, CureApp aims to improve patient outcomes and enhance the overall treatment experience. Their offerings include mobile health programs tailored for corporate wellness, promoting health management and preventative care in the workplace. CureApp's digital therapies provide personalized interventions, extending medical support beyond conventional clinical settings.
How much funding has CureApp raised?
CureApp has raised a total of $44.7M across 1 funding round:
Series G
$44.7M
Series G (2022): $44.7M with participation from Carlyle
Key Investors in CureApp
Carlyle
Carlyle is a global investment firm specializing in private equity, managing numerous funds across buyouts, venture and growth capital, real estate, and leveraged finance. Their worldwide presence and diverse investment strategy enable them to identify and pursue opportunities across various markets and sectors.
What's next for CureApp?
The substantial enterprise-level funding indicates CureApp is poised for significant scaling and further development of its digital therapeutic platforms. This strategic investment will likely fuel expansion into new markets, accelerate research and development for novel digital treatments, and enhance the company's technological infrastructure. CureApp's focus on evidence-based software solutions positions it for continued growth in the rapidly evolving digital health sector, aiming to address unmet medical needs and improve patient care globally.
See full CureApp company page
